Physician profile
Kari L Smith
NPI 1114935368
$4,776.61
in general payments reported to CMS, 2019-2025
10 companies · $3,436 in 2025
The $3,436 reported for 2025 was more than what 98% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $1,137 · 2024: $203 · 2025: $3,436.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,000 · Travel and Lodging: $892 · Food and Beverage: $885.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,000.00 |
| Travel and Lodging | $891.91 |
| Food and Beverage | $884.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $4,391.70 | 2023-2025 | Watchman, Watchman Access System, Watchman Flx |
| Medtronic, INC. | $162.17 | 2024-2025 | Micra |
| Cvrx, INC. | $63.39 | 2024 | Barostim Neo System |
| E.R. Squibb & Sons, L.L.C. | $59.55 | 2024-2025 | Camzyos, Eliquis |
| Regeneron Healthcare Solutions, INC. | $21.20 | 2024 | Evkeeza |
| Novartis Pharmaceuticals Corporation | $17.20 | 2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $16.66 | 2024 | Lifevest |
| Abbott Laboratories | $16.38 | 2024 | Cardiomems |
| Amgen INC. | $14.39 | 2023 | Repatha |
| Pfizer INC. | $13.97 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kari Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.